UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV‐1 reservoirs: results from a multicentre randomized clinical study

HIV medicine, 2012-05, Vol.13 (5), p.291-296

2012

Volltextzugriff (PDF)

Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up

Clinical infectious diseases, 2013-02, Vol.56 (4), p.567-575

2013

Volltextzugriff (PDF)

Motzkin subposets and Motzkin geodesics in Tamari lattices

Information processing letters, 2014-01, Vol.114 (1-2), p.31-37

2014

Volltextzugriff (PDF)

Noise-induced hearing loss and combined noise and vibration exposure

Occupational medicine (Oxford), 2015-04, Vol.65 (3), p.238-244

2015

Volltextzugriff (PDF)

A meta‐analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir‐boosted protease inhibitor maintenance therapy in HIV‐infected adults with established virological suppression after induction

HIV medicine, 2014-05, Vol.15 (5), p.301-310

2014

Volltextzugriff (PDF)

Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation

Clinical infectious diseases, 2013-11, Vol.57 (10), p.1489-1496

2013

Volltextzugriff (PDF)

Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection

International journal of STD & AIDS, 2011-03, Vol.22 (3), p.146-150

2011

Volltextzugriff (PDF)

SUSTAINED SMOKING ABSTINENCE 12 MONTHS AFTER ACUTE CORONARY SYNDROME: FOLLOW-UP FROM A RANDOMIZED CONTROLLED TRIAL OF VARENICLINE IN HOSPITALIZED PATIENTS

Canadian journal of cardiology, 2016-10, Vol.32 (10), p.S109-S110

2016

Volltextzugriff (PDF)

The irregularity strength of circulant graphs

Discrete mathematics, 2005-11, Vol.304 (1), p.1-10

2005

Volltextzugriff (PDF)

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

The Journal of infectious diseases, 2007-04, Vol.195 (7), p.951-959

2007

Volltextzugriff (PDF)

Formation of Semisolid, Oligomerized Aqueous SOA: Lab Simulations of Cloud Processing

Environmental science & technology, 2014-02, Vol.48 (4), p.2273-2280

2014

Volltextzugriff (PDF)

Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection

The Journal of immunology (1950), 2003-07, Vol.171 (1), p.477-488

2003

Volltextzugriff (PDF)

Tunisie, l'après 2011: Enquête sur les transformations de la société tunisienne

2022

Volltextzugriff (PDF)

A randomized herd-level field study of dietary interactions with monensin on milk fat percentage in dairy cows

Journal of dairy science, 2009-02, Vol.92 (2), p.777-781

2009

Volltextzugriff (PDF)

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

The Lancet (British edition), 2013-03, Vol.381 (9868), p.735-743

2013

Volltextzugriff (PDF)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Volltextzugriff (PDF)

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

The Lancet (British edition), 2009-09, Vol.374 (9692), p.796-806

2009

Volltextzugriff (PDF)

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK

Journal of acquired immune deficiency syndromes (1999), 2013-05, Vol.63 (1), p.77-85

2013

Volltextzugriff (PDF)

Hepatic epithelioid hemangioendothelioma: a challenging disease

HPB (Oxford, England), 2024, Vol.26, p.S682-S683

2024

Volltextzugriff (PDF)

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.339-354

2008

Volltextzugriff (PDF)

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.355-365

2008

Volltextzugriff (PDF)

Determinants of early ART initiation during primary HIV infection: implications for HIV cure research

Journal of Virus Eradication, 2017-12, Vol.3, p.43-44

2017

Volltextzugriff (PDF)

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596

2013

Volltextzugriff (PDF)

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

Journal of acquired immune deficiency syndromes (1999), 2010-09, Vol.55 (1), p.39-48

2010

Volltextzugriff (PDF)

Computerized Clinical Decision Support During Medication Ordering for Long-term Care Residents with Renal Insufficiency

Journal of the American Medical Informatics Association : JAMIA, 2009-07, Vol.16 (4), p.480-485

2009

Volltextzugriff (PDF)

1 – 25 von 1.088

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(690)
Mit Volltextzugriff
(666)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(376)
Life Sciences & Biomedicine
(312)
Humans
(255)
Female
(163)
Male
(147)
Biological And Medical Sciences
(132)
Adult
(107)
Middle Aged
(104)
Life Sciences
(77)
Medical Sciences
(76)
Aged
(67)
Animals
(66)
Fundamental And Applied Biological Sciences. Psychology
(66)
Infectious Diseases
(62)
Immunology
(47)
Agriculture
(45)
Hiv
(43)
Physical Sciences
(43)
Hiv Infections - Drug Therapy
(38)
Human Immunodeficiency Virus
(38)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Valproic acid in association with highly active antiretroviral therapy for reducing systemic HIV‐1 reservoirs: results from a multicentre randomized clinical study

Association Between Tenofovir Exposure and Reduced Kidney Function in a Cohort of HIV-Positive Patients: Results From 10 Years of Follow-up

Motzkin subposets and Motzkin geodesics in Tamari lattices

Noise-induced hearing loss and combined noise and vibration exposure

A meta‐analysis of the efficacy and safety of unboosted atazanavir compared with ritonavir‐boosted protease inhibitor maintenance therapy in HIV‐infected adults with established virological suppression after induction

Virologic Failure Following Persistent Low-level Viremia in a Cohort of HIV-Positive Patients: Results From 12 Years of Observation

Effect of antiretroviral therapy on HIV-1 genetic evolution during acute infection

SUSTAINED SMOKING ABSTINENCE 12 MONTHS AFTER ACUTE CORONARY SYNDROME: FOLLOW-UP FROM A RANDOMIZED CONTROLLED TRIAL OF VARENICLINE IN HOSPITALIZED PATIENTS

The irregularity strength of circulant graphs

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

Formation of Semisolid, Oligomerized Aqueous SOA: Lab Simulations of Cloud Processing

Longitudinal Assessment of Changes in HIV-Specific Effector Activity in HIV-Infected Patients Starting Highly Active Antiretroviral Therapy in Primary Infection

Tunisie, l'après 2011: Enquête sur les transformations de la société tunisienne

A randomized herd-level field study of dietary interactions with monensin on milk fat percentage in dairy cows

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK

Hepatic epithelioid hemangioendothelioma: a challenging disease

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

Determinants of early ART initiation during primary HIV infection: implications for HIV cure research

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Raltegravir versus Efavirenz regimens in treatment-naive HIV-1-infected patients: 96-week efficacy, durability, subgroup, safety, and metabolic analyses

Computerized Clinical Decision Support During Medication Ordering for Long-term Care Residents with Renal Insufficiency

Suchergebnisse filtern